Additionally, intraperitoneal injection of mice with recombinant RELMα increased C. rodentium-induced colitis, including increased IL-17, whereas IL-17A−/− mice did not display increased colitis in response to RELMα treatment (185). This evidence concerns the gene IL17A and colitis.